Table 2

Descriptive statistics of the study population of the current manual work analysis and the dose–response analysis, before and after propensity score matching

Manual work statusCurrent manual work analysisDose–response analysis
UnmatchedMatchedUnmatchedMatched
Exposed (usually/always)Unexposed (rarely/never)SMDExposed (usually/always)Unexposed (rarely/never)SMDExposed (usually/always)Unexposed (rarely/never)SMDExposed (usually/always)Unexposed (rarely/never)SMD
N26 667169 59826 667100 21312 31284 25112 31246 624
Age, mean (SD)52.73 (7.15)52.98 (7.07)−0.03552.73 (7.15)52.81 (7.18)−0.00153.27 (7.07)53.26 (6.91)0.00153.27 (7.07)53.30 (7.01)0.002
Sex, m (%)16 943 (63.5)79 115 (46.6)0.35316 943 (63.5)61 593 (61.5)0.0018187 (66.5)39 350 (46.7)0.4198187 (66.5)30 259 (64.9)0.004
DM (%)1225 (4.6)6960 (4.1)0.0231225 (4.6)4592 (4.6)0.004549 (4.5)3142 (3.7)0.035549 (4.5)2031 (4.4)0.002
Smoker (%)13 087 (49.1)70 713 (41.7)0.14813 087 (49.1)47 537 (47.4)0.0055740 (46.6)33 134 (39.3)0.1465740 (46.6)20 992 (45.0)0.006
Alcohol (%)
 (Never)1564 (5.9)7800 (4.6)0.0541564 (5.9)5480 (5.5)<0.001714 (5.8)3774 (4.5)0.057714 (5.8)2534 (5.4)0.001
 (Special occasions only)2971 (11.1)14 598 (8.6)0.0812971 (11.1)10 287 (10.3)0.0081231 (10.0)7005 (8.3)0.0561231 (10.0)4357 (9.3)0.008
(1–3 times a month)3361 (12.6)19 622 (11.6)0.0313361 (12.6)12 447 (12.4)<0.0011468 (11.9)9311 (11.1)0.0271468 (11.9)5410 (11.6)0.003
(1–2 times a week)8320 (31.2)47 166 (27.8)0.0738320 (31.2)30 857 (30.8)<0.0013782 (30.7)23 187 (27.5)0.0693782 (30.7)14 090 (30.2)0.002
(3–4 times a week)5811 (21.8)44 771 (26.4)−0.1125811 (21.8)22 779 (22.7)−0.0012821 (22.9)22 882 (27.2)−0.1012821 (22.9)11 119 (23.8)−0.003
 ((Almost) daily)4640 (17.4)35 641 (21.0)−0.0964640 (17.4)18 363 (18.3)−0.0062296 (18.6)18 092 (21.5)−0.0742296 (18.6)9114 (19.5)−0.007
Triglyc. (mmol/l), mean (SD)1.78 (1.10)1.70 (1.02)0.0741.78 (1.10)1.77 (1.06)0.0021.77 (1.09)1.68 (1.01)0.0891.77 (1.09)1.77 (1.06)−0.003
LDL (mmol/l), mean (SD)3.59 (0.83)3.57 (0.83)0.0243.59 (0.83)3.59 (0.84)<0.0013.60 (0.83)3.58 (0.83)0.0343.60 (0.83)3.60 (0.84)0.006
HDL (mmol/l), mean (SD)1.41 (0.36)1.45 (0.37)−0.1121.41 (0.36)1.41 (0.37)0.0061.41 (0.36)1.46 (0.38)−0.1451.41 (0.36)1.41 (1.37)0.005
BMI, mean (SD)27.63 (4.59)27.21 (4.69)0.09027.63 (4.59)27.55 (4.73)0.00227.59 (4.49)27.05 (4.64)0.12127.59 (4.49)27.49 (4.70)0.006
Hypertension (%)7129 (26.7)40 721 (24.0)0.0627129 (26.7)26 361 (26.3)0.0013257 (26.5)20 002 (23.7)0.0623257 (26.5)12 162 (26.1)<0.001
TDI, mean (SD)−0.90 (3.07)−1.70 (2.80)0.261−0.90 (3.07)−1.14 (3.01)−0.011−1.15 (2.97)−1.83 (2.72)0.229−1.15 (2.97)−1.35 (2.91)0.013
Respiratory disease (%)3795 (14.2)24 095 (14.2)−0.0013795 (14.2)14 189 (14.2)−0.0011684 (13.7)11 732 (13.9)0.0071684 (13.7)6377 (13.7)−0.001
  • Because participants with missing values were excluded before PSM, there was no missingness of baseline covariates.

  • BMI, body mass index; DM, diabetes mellitus; HDL, high-density lipoprotein; LDL, low-density lipoprotein; SMD, standardised mean difference between exposed and unexposed participants; TDI, Townsend Deprivation Index; Triglyc., triglycerides.